Public Alert Regarding WHO Alert on Falsified DEFITELIO (Defibrotide) 80 mg/ml Concentrate for Solution for Infusion, B. No. 24GC01A, Expiry Date 04/2027, Manufactured by Patheon, Italy, and Marketing Authorisation Holder Gentium S.r.l., Identified in India Drugs

Updated on: 23rd Oct, 2026

location Central 
The Central Drugs Standard Control Organisation, vide File No. Enforc-11013(11)/10/2026-eoffice, issued a public alert regarding the WHO alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, Batch No. 24GC01A, expiry date 04/2027, manufactured by Patheon, Italy, with Gentium S.r.l. as the marketing authorisation holder, identified in India. Please refer to the public alert for more details.
Loading document…
Login to Download
PREVIOUS
Notification of the Central Motor Vehicles (Amendment) Rules, 2026
NEXT
Notification on Revised Standards for Telecommunication Equipment under the Telecommunications Act, 2023